Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2200055284Phase 4Recruiting
Phase 4, open-label trial of alfentanil (3 arms), sponsored by The 2nd Affiliated Hospital of Chongqing Medical University. Primary endpoint: Activity of diaphragm. Started Jan 2022; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2200055284.